Alstonia macrophylla

Alstonia macrophylla contains indole alkaloids that exhibit antimalarial activity by interfering with Plasmodium parasite development. These alkaloids may inhibit plasmodial growth through multiple pathways, though the exact mechanism requires further research. The plant also contains flavonoids and tannins that contribute to its antipyretic and anti-inflammatory effects, helping reduce fever associated with malaria. Current evidence is rated at Level C, based primarily on in vitro and animal studies rather than human clinical trials.

No specific clinical drug interaction studies exist for Alstonia macrophylla. However, due to its alkaloid content and potential effects on liver metabolism, it may theoretically interact with medications processed by the hepatic cytochrome P450 enzyme system. Patients taking antimalarial drugs, anticoagulants, or medications metabolized by the liver should exercise caution. The herb is contraindicated in individuals with liver disease. Always consult a healthcare provider before combining this herb with prescription medications.

The traditional adult dosage for Alstonia macrophylla bark is 5-10 grams prepared as a decoction, taken twice daily. To prepare, simmer the dried bark in water for 15-20 minutes, then strain before consumption. This dosage is based on ethnomedicinal use and traditional practice rather than standardized clinical trials (Evidence Level C). Start with the lower dose to assess tolerance, as higher doses may cause gastrointestinal upset. Consult a qualified herbalist or healthcare provider for personalized dosing guidance.

Alstonia macrophylla is contraindicated during pregnancy and breastfeeding. The plant contains bioactive alkaloids that may cross the placental barrier and potentially affect fetal development. Traditional evidence suggests the herb may possess uterine-stimulating properties, which could pose a risk of miscarriage or premature labor. There is insufficient safety data for use during lactation. Women who are pregnant, planning pregnancy, or breastfeeding should avoid this herb entirely and consult a healthcare provider for alternative treatments.

Alstonia macrophylla bark has been used traditionally in Southeast Asian medicine to treat fever, malaria, and diarrhea. Indigenous communities have employed it as an antipyretic to reduce high temperatures and as an anti-malarial remedy. The bark is also valued for its astringent properties in managing gastrointestinal conditions like dysentery. These uses are based on ethnomedicinal knowledge and limited pharmacological studies (Evidence Level C), rather than extensive human clinical trials. It is often used similarly to the related species Alstonia scholaris.

The most commonly reported side effects of Alstonia macrophylla are gastrointestinal disturbances, including nausea, vomiting, abdominal discomfort, and diarrhea. These effects are typically dose-dependent and may be reduced by taking the herb with food. Due to its alkaloid content, excessive doses could potentially affect liver function, which is why it is contraindicated in individuals with liver disease. Long-term safety data is lacking. Discontinue use if adverse reactions occur and seek medical attention if symptoms persist or worsen.